CRVW (CareView Communications) Research & Development: $2.45 Mil (TTM As of Mar. 2026)


What is CareView Communications Research & Development?

CareView Communications CRVW Research & Development is $2.45 Mil as of Mar. 2026. The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CareView Communications's Research & Development for the three months ended in Mar. 2026 was $0.62 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $2.45 Mil.

CareView Communications  (OTCPK:CRVW) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CareView Communications Research & Development Related Terms

CareView Communications Research & Development Historical Data

* Premium members only.

The historical data trend for CareView Communications's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CareView Communications Research & Development Chart

CareView Communications Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.71 1.97 2.50 2.35 2.41

CareView Communications Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.55 0.61 0.68 0.62

CareView Communications Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $2.45 Mil mean?
CareView Communications (CRVW) has a Research & Development of $2.45 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on CareView Communications and its competitors.
Is CareView Communications' Research & Development too high?
CareView Communications' current Research & Development is $2.45 Mil.
How does CareView Communications' Research & Development compare to VASO and ONMD?
CareView Communications' Research & Development of $2.45 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CareView Communications and its competitors. CareView Communications's current Research & Development is $2.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CareView Communications stock overvalued right now?
Based on GuruFocus' analysis, CareView Communications (CRVW) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.03, compared to a current price of $0.06 — trading 83.3% above its estimated fair value. The current Research & Development is $2.45 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CareView Communications (CRVW), the current Research & Development is $2.45 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CareView Communications Business Description

Address 405 State Highway 121 Bypass, Suite B-240, Lewisville, TX, USA, 75067
CareView Communications Inc is engaged in providing products and on-demand application services for the healthcare industry, specializing in bedside video monitoring, software tools to improve hospital communications and operations, and patient education and entertainment packages. It has developed a data network system called CareView System, which is a suite of video monitoring, guest services, and related applications that connect patients, families, and healthcare providers. The company also provides services to increase patient satisfaction scores and enhance the overall image of the hospital, including on-demand movies and video visits. The business consists of a single segment of products and services, all of which are sold and provided within the United States.